QUOTED. Jan. 7, 2019. Bonnie Anderson.
Diagnostics firm Veracyte signed a deal to combine clinical study cohorts with Johnson & Johnson to accelerate development of two nasal swab tests for early detection of lung cancer. See how CEO Bonnie Anderson describes the arrangement here.
Click here for a free trial of Medtech Insight